BioNexus Gene Lab Corp (BGLC)
0.442
-0.04
(-7.72%)
USD |
NASDAQ |
Jun 14, 16:00
0.44
0.00 (0.00%)
After-Hours: 20:00
BioNexus Gene Lab Free Cash Flow (Quarterly): -0.0564M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -0.0564M |
December 31, 2023 | -0.2628M |
September 30, 2023 | -1.033M |
June 30, 2023 | -0.0382M |
March 31, 2023 | -0.1166M |
December 31, 2022 | 0.4597M |
September 30, 2022 | 0.3052M |
June 30, 2022 | -0.1973M |
March 31, 2022 | -0.07M |
December 31, 2021 | 0.4817M |
September 30, 2021 | 0.3155M |
Date | Value |
---|---|
June 30, 2021 | -0.9058M |
March 31, 2021 | 0.1146M |
December 31, 2020 | 0.5112M |
September 30, 2020 | 0.7547M |
June 30, 2020 | -0.1572M |
March 31, 2020 | -0.9777M |
December 31, 2019 | -0.0655M |
September 30, 2019 | -0.0539M |
June 30, 2019 | -0.0475M |
March 31, 2019 | -0.0632M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-1.033M
Minimum
Sep 2023
0.7547M
Maximum
Sep 2020
-0.052M
Average
-0.0552M
Median
Free Cash Flow (Quarterly) Benchmarks
Balchem Corp | 26.48M |
Friedman Industries Inc | 2.944M |
Solitario Resources Corp | -0.991M |
Golden Minerals Co | -1.442M |
Paramount Gold Nevada Corp | -1.588M |